HEATHER CHEEK: Open Payments
NPI 1740235407 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 46 payments from 19 companies in 2025. Trend: 2023 $1,731 · 2024 $811 · 2025 $1,194
Food & beverage: $1,194
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $186 |
| Kite Pharma, Inc. | 2 | $168 |
| AstraZeneca Pharmaceuticals LP | 6 | $124 |
| PFIZER INC. | 5 | $121 |
| E.R. Squibb & Sons, L.L.C. | 5 | $111 |
| BeOne Medicines USA, Inc. | 3 | $77 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Lilly USA, LLC | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $38 |
Products named: Yescarta, KISQALI, OPDIVO, IBRANCE, SCEMBLIX, BRUKINSA, KEYTRUDA, VERZENIO.
Industry payments across SC — which companies pay providers there.
